NO930781L - Vandige farmasoeytiske preparater av natriumkromoglykat - Google Patents

Vandige farmasoeytiske preparater av natriumkromoglykat

Info

Publication number
NO930781L
NO930781L NO930781A NO930781A NO930781L NO 930781 L NO930781 L NO 930781L NO 930781 A NO930781 A NO 930781A NO 930781 A NO930781 A NO 930781A NO 930781 L NO930781 L NO 930781L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
aqueous pharmaceutical
sodium chromoglycate
chromoglycate
sodium
Prior art date
Application number
NO930781A
Other languages
English (en)
Other versions
NO302398B1 (no
NO930781D0 (no
Inventor
Graham Frederick Jay
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10718322&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO930781(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of NO930781D0 publication Critical patent/NO930781D0/no
Publication of NO930781L publication Critical patent/NO930781L/no
Publication of NO302398B1 publication Critical patent/NO302398B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO930781A 1992-07-07 1993-03-03 Vandige farmasöytiske preparater av natriumkromoglykat og farmasöytisk forpakning NO302398B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929214390A GB9214390D0 (en) 1992-07-07 1992-07-07 Formulations

Publications (3)

Publication Number Publication Date
NO930781D0 NO930781D0 (no) 1993-03-03
NO930781L true NO930781L (no) 1994-01-10
NO302398B1 NO302398B1 (no) 1998-03-02

Family

ID=10718322

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930781A NO302398B1 (no) 1992-07-07 1993-03-03 Vandige farmasöytiske preparater av natriumkromoglykat og farmasöytisk forpakning

Country Status (12)

Country Link
US (1) US5475023A (no)
EP (1) EP0587264B1 (no)
JP (1) JP2916340B2 (no)
BE (1) BE1005196A0 (no)
CA (1) CA2090911C (no)
DE (1) DE69300017T2 (no)
DK (1) DK0587264T3 (no)
FR (1) FR2686513B1 (no)
GB (1) GB9214390D0 (no)
IE (1) IE64551B1 (no)
IT (1) ITMI20011389A1 (no)
NO (1) NO302398B1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576346A (en) * 1995-04-03 1996-11-19 Ascent Pharmaceuticals, Inc. Process for treating uremic pruritus
US5552436A (en) * 1995-04-03 1996-09-03 Ascent Pharmaceuticals, Inc. Process for treating hemangioma
US5532270A (en) * 1995-04-03 1996-07-02 Ascent Pharmaceuticals, Inc. Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions
EP1421940A4 (en) * 2001-08-09 2006-02-08 Sekisui Chemical Co Ltd MEDICAL COMPOSITION FOR EXTERNAL USE FOR THE TREATMENT OF DERMATOSES
US6596284B1 (en) 2002-04-30 2003-07-22 Thomas E. Fleming Treating eczema with a combination of isotonic saline ocean® and nasal mast cell stabilizers
ES2457442T3 (es) 2009-05-08 2014-04-25 Pari Pharma Gmbh Formulaciones farmacéuticas concentradas estabilizadoras de los mastocitos
WO2015120389A1 (en) 2014-02-10 2015-08-13 Patara Pharma, LLC Mast cell stabilizers treatment for systemic disorders
PT3104854T (pt) 2014-02-10 2020-06-26 Respivant Sciences Gmbh Estabilizadores de mastócitos para tratamento de doença pulmonar
WO2017027387A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of mast cell related disorders with mast cell stabilizers
WO2017027402A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
EP3506893A4 (en) 2016-08-31 2020-01-22 Respivant Sciences GmbH CROMOLYNE COMPOSITIONS FOR THE TREATMENT OF CHRONIC COUGH DUE TO IDIOPATHIC PULMONARY FIBROSIS
AU2017339366A1 (en) 2016-10-07 2019-04-11 Respivant Sciences Gmbh Cromolyn compositions for treatment of pulmonary fibrosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1473318A (en) * 1973-05-25 1977-05-11 Fisons Ltd Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
US3975536A (en) * 1971-05-12 1976-08-17 Fisons Limited Composition
GB1593097A (en) * 1978-05-26 1981-07-15 Fisons Ltd Pharmaceutical compositions containing a bischromone
JPH0218393A (ja) * 1988-07-06 1990-01-22 Nitto Chem Ind Co Ltd 人工水晶の製造方法
WO1990013284A1 (en) * 1989-04-29 1990-11-15 Fisons Plc Pharmaceutical composition containing sodium cromoglycate
EP0413583A3 (en) * 1989-08-18 1991-07-17 Dey Laboratories; Inc. Clear, stable cromolyn formulation

Also Published As

Publication number Publication date
IE930148A1 (en) 1994-01-12
EP0587264B1 (en) 1994-10-26
FR2686513B1 (fr) 1995-05-24
ITMI20011389A0 (it) 2001-06-29
ITMI20011389A1 (it) 2002-12-29
NO302398B1 (no) 1998-03-02
NO930781D0 (no) 1993-03-03
GB9214390D0 (en) 1992-08-19
JP2916340B2 (ja) 1999-07-05
JPH0672869A (ja) 1994-03-15
US5475023A (en) 1995-12-12
BE1005196A0 (fr) 1993-05-18
CA2090911C (en) 2004-05-18
IE64551B1 (en) 1995-08-23
DE69300017T2 (de) 1995-03-30
FR2686513A1 (fr) 1993-07-30
EP0587264A1 (en) 1994-03-16
CA2090911A1 (en) 1994-01-08
DK0587264T3 (da) 1995-03-06
DE69300017D1 (de) 1994-12-01

Similar Documents

Publication Publication Date Title
PL318132A1 (en) Aqueous preparations of risperidone
FI943707A0 (fi) Stabiloidut vesipitoiset nestemäiset fytaasivalmisteet
FI941777A0 (fi) Vesipitoinen farmaseuttinen suspensio ja menetelmä sen valmistamiseksi
HU9303282D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
FI930882A0 (fi) Farmaceutiska foereningar
BR9006934A (pt) Formulacoes aquosas estabilizadas de pequenos peptidios
HU9303283D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
NO930781D0 (no) Vandige farmasoeytiske preparater av natriumkromoglykat
ITMI921413A0 (it) Preparazioni farmaceutiche stabili di nicorandil
IT1198247B (it) Formulazioni farmaceutiche acquose di ubichinone
DE69329933D1 (de) 17-beta-carboxanilid derivate von 4-aza-5-alpha-androstan-3-one als 5-alpha-reduktase-hemmende arzneimittel
FI931251A0 (fi) Farmaceutiska foereningar
FI951092A0 (fi) Fluoreseiinijohdannaisten stabiilit korkeakonsentroidut valmisteet
DK99085D0 (da) Farmaceutiske praeparater indeholdende a-vitaminsyrederivater
NO951933L (no) Farmasöytiske formuleringer av ibuprofen
BR9307182A (pt) Composições farmacêuticas de 2-oxindol-1-carboxamidas 3-substituídas
GB2262448B (en) Aqueous pharmaceutical formulations of sodium cromoglycate
MX9203932A (es) Preparaciones acuosas de substancias tensioactivas
DE69313442D1 (de) Hydroxyderivate von cyclohexadien
NO920039D0 (no) Farmasoeytiske preparater
NO950646D0 (no) Stabile, meget konsentrerte preparater av fluorescein-derivater
BR9306699A (pt) Derivados do triazoliletanol
FR2587217B1 (fr) Preparations pharmaceutiques immunomodulantes
NO920564L (no) Farmasoeytiske adenosinholdige preparater

Legal Events

Date Code Title Description
MK1K Patent expired